LWA
MGNX icon

Lantern Wealth Advisors’s MacroGenics MGNX Stock Holding History

Lantern Wealth Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.2K Buy
+26,700
New +$57K 0.04% 172

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Lantern Wealth Advisors's MGNX Position: Q1 2026 in Review

Lantern Wealth Advisors opened a new position in MacroGenics (MGNX) in Q1 2026: 26,700 shares worth $77.2K. The stake represents 0.04% of the portfolio and ranks #172 among its holdings.

109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Lantern Wealth Advisors held 26,700 shares of MacroGenics worth $77.2K as of Q1 2026.
  • MacroGenics was a new Lantern Wealth Advisors position in Q1 2026.
  • MacroGenics made up 0.04% of Lantern Wealth Advisors's portfolio in Q1 2026, its #172 holding.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Lantern Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.